Emblem Corp EMMBF

RE:RE:4 current buy ratings 1 hold and a target price of $2.32

[Crosby087]

Yeah , EMC hasn’t done much in 2018, other than :

• Generated $1.3 million in revenue & Cannabis oil sales represented 29% of Q1 patient revenue
• 2,950 registered patients as of March 31, 2018
• Signed a key supplier agreement to become a medical cannabis supplier to Shoppers Drug Mart Inc.
• $53.8 million financing increased cash balance to $83.8 million as at March 31, 2018
• Purchased remaining 50% of GrowWise Health Limited
• Progressed on expansion plans to increase annual capacity to approximately 17,000kg
• Construction progressing on 30,000 square foot Phase 3 expansion at the Woodslee Production Facility with GMP extraction facility, laboratory and pharmaceutical production facility
• Invested in Fire & Flower Inc. and entered into the 3-year preferred supplier agreement
• Increased patient count 22% to approximately 3,600 patients at May 28, 2018, since March 31, 2018
• Commenced R&D on oral sustained release formulations in collaboration with Canntab Therapeutics Limited (“Canntab”)
• Commenced inventory build for the legalization of adult-use recreational cannabis in Canada